 Bank of New York Mellon Corp increased its position in shares of Aeglea Bio Therapeutics Inc NASDAQ:AGLE by 5.3 in the first quarter, according to its most recent disclosure with the Securities Exchange Commission. The fund owned 95,106 shares of the biotechnology companys stock after buying an additional 4,763 shares during the period. Bank ... 